Cancer Family
Digestive System Neoplasm
CI-CAN-00000012Explore in graph →
Non-malignant4,733 active trials43 approved drugs557 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000012Explore in graph →
Clinical trials
22,059 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT07196384 | Optical PD-1 and PD-L1 Imaging in Locally Advanced Esophageal Cancer Using Durvalumab-680LT and Nivolumab-800CW(GLOW) | not yet recruiting | Phase 1 | 15 | University Medical Center GroningenOTHER | 0 | Nov 21, 2025 | clinicaltrials |
| NCT07241143 | Extra-Peritoneal Tunneling Versus Conventional Drain Fixation After Anterior or Low Anterior Resection(ExPeTuD) | not yet recruiting | N/A | 596 | Yeungnam University HospitalOTHER |
| 1 |
| Nov 21, 2025 |
| clinicaltrials |
| NCT07242911 | Study on Efficacy and Safety of VMAT Technique With Local Dose Escalation for Unresectable Pancreatic Cancer | not yet recruiting | — | 30 | Chifeng Tumor HospitalOTHER | 1 | Nov 21, 2025 | clinicaltrials |
| NCT07239986 | A Phase 2 Study of BB102 in Patients With Hepatocellular Carcinoma | not yet recruiting | Phase 2 | 60 | Broadenbio Ltd., Co.INDUSTRY | 1 | Nov 20, 2025 | clinicaltrials |
| NCT07236827 | A Comparison of Endoscopic Synchronous Injection and Submucosal Dissection(ESISD) and Conventional Endoscopic Submucosal Dissection(CESD) for Granular Mixed Nodular Laterally Spreading Tumor in the Rectum (LST-G-M)(ESISD vs CESD) | not yet recruiting | N/A | 60 | Taihe HospitalOTHER | 0 | Nov 19, 2025 | clinicaltrials |
| NCT07237204 | 15 vs 45 Minute Pringle Maneuver in Liver Cancer Resection: Randomized Noninferiority Trial | not yet recruiting | N/A | 600 | Medical University of WarsawOTHER | 1 | Nov 19, 2025 | clinicaltrials |
| NCT06177522 | Adebrelimab Combined With Chemotherapy for Neoadjuvant Therapy in Resectable Pancreatic Cancer | not yet recruiting | Phase 2 | 30 | Jinling Hospital, ChinaOTHER | 1 | Nov 18, 2025 | clinicaltrials |
| NCT07233850 | A Phase II Clinical Study Evaluating SSGJ-706 in Combination Therapy for Advanced Gastrointestinal Cancers | not yet recruiting | Phase 2 | 300 | Shenyang Sunshine Pharmaceutical Co., LTD.INDUSTRY | 1 | Nov 18, 2025 | clinicaltrials |
| NCT07229872 | A Phase II Clinical Study of Aipalolitovorelizumab (QL1706) Combined With Fruquintinib in the Treatment of Immunodominant pMMR/MSS Metastatic Colorectal Cancer That Has Failed Second-line or Above Treatment | not yet recruiting | Phase 2 | 18 | Harbin Medical UniversityOTHER | 0 | Nov 17, 2025 | clinicaltrials |
| NCT07230314 | Sequential Transarterial Chemoembolization (TACE), Stereotactic Body Radiation Therapy (SBRT), and Immune Checkpoint Inhibitors for Unresectable Hepatocellular Carcinoma Treated With Donafenib | not yet recruiting | Phase 2 | 34 | Jinling Hospital, ChinaOTHER | 0 | Nov 17, 2025 | clinicaltrials |
| NCT07224568 | Cytokine Armored GPC3 Specific Chimeric Antigen Receptor Expressing T-cells in Adults With Solid Tumors(INTERCEPT) | not yet recruiting | Phase 1 | 21 | Seattle Children's HospitalOTHER | 1 | Nov 4, 2025 | clinicaltrials |
| NCT07191548 | International Study on Treatment of Patients With Metastatic Colorectal Liver Lesions Patients With IRE(LIVERMET-IRE) | not yet recruiting | N/A | 50 | Angiodynamics, Inc.INDUSTRY | 1 | Oct 10, 2025 | clinicaltrials |
| NCT07192731 | International Study on Treatment of Liver (HCC) Patients With IRE(LIVERHCC-IRE) | not yet recruiting | N/A | 50 | Angiodynamics, Inc.INDUSTRY | 1 | Oct 10, 2025 | clinicaltrials |
| NCT07209384 | Clinical Efficacy of Transarterial Chemoembolization in Elderly Patients With Advanced Unresectable Colorectal Cancer | not yet recruiting | Phase 2 | 50 | Junpeng WangOTHER | 0 | Oct 7, 2025 | clinicaltrials |
| NCT07211009 | Patient-Reported Symptom Care Versus Usual Care After Esophageal Cancer Surgery: A Single-Center Phase 3 Randomized Trial | not yet recruiting | Phase 3 | 240 | Sichuan UniversityOTHER | 0 | Oct 7, 2025 | clinicaltrials |
| NCT05832138 | ONLOOP Trial: Evaluating a New Surveillance and Support System for Survivors of Childhood Cancer in Ontario | not yet recruiting | N/A | 900 | The Hospital for Sick ChildrenOTHER | 0 | Oct 6, 2025 | clinicaltrials |
| NCT07208526 | A Randomized Trial of Surgical Decision-Making Guided by TDTP-RECIST | not yet recruiting | N/A | 270 | Shanghai Zhongshan HospitalOTHER | 1 | Oct 6, 2025 | clinicaltrials |
| NCT07208539 | AG Followed by FOLFIRINOX Both Combined With PD-L1 Antibodies as a Conversion Therapy for Borderline Resectable and Locally Advanced Pancreatic Cancer.(ZSPAC-14) | not yet recruiting | Phase 2 | 77 | Shanghai Zhongshan HospitalOTHER | 0 | Oct 6, 2025 | clinicaltrials |
| NCT07206511 | Conversion Therapy Using TACE/HAIC With Anti-Angiogenic and Immunotherapy for Initially Unresectable Hepatocellular Carcinoma Achieving Complete Response or Resectability, Followed by Surgery or Continued Systemic Treatment: A Prospective Cohort Study(THAI-CONVERT) | not yet recruiting | — | 278 | Shanghai Zhongshan HospitalOTHER | 0 | Oct 3, 2025 | clinicaltrials |
| NCT02968069 | A Predictive Model Based on Narrow Band Imaging for Early Gastric Cancerous Lesions | not yet recruiting | N/A | 300 | Shanghai Jiao Tong University School of MedicineOTHER | 0 | Oct 2, 2025 | clinicaltrials |
| NCT07203690 | Development and Application of AI-Based Therapeutic Strategies for Esophageal Cancer Integrating Multimodal Imaging and Digital Pathology | not yet recruiting | — | 7,000 | Henan Cancer HospitalOTHER_GOV | 0 | Oct 2, 2025 | clinicaltrials |
| NCT07203898 | A Study of IPM514 in Patients With Esophageal Squamous Cell Carcinoma. | not yet recruiting | Phase 1 | 36 | Beijing Immupeutics Medicine Technology LimitedINDUSTRY | 0 | Oct 2, 2025 | clinicaltrials |
| NCT07201064 | A Study of SZ1003 Injection in Patients With Advanced Hepatocellular Carcinoma | not yet recruiting | Early Phase 1 | 12 | Guangdong ProCapZoom Biosciences Co., Ltd.INDUSTRY | 0 | Oct 1, 2025 | clinicaltrials |
| NCT07201857 | Peri-habilitation for Patients With Gastric Cancer | not yet recruiting | N/A | 30 | Korea University Anam HospitalOTHER | 1 | Oct 1, 2025 | clinicaltrials |
| NCT07115875 | Improving Rates of Diagnostic Colonoscopy in Native Americans(YVONNE-DX) | not yet recruiting | N/A | 164 | University of OklahomaOTHER | 1 | Sep 30, 2025 | clinicaltrials |
| NCT07198321 | A Single-Arm, Open-Label, Multicenter Phase I/II Clinical Study of GFH276 in Patients With RAS-Mutant Advanced Solid Tumors | not yet recruiting | Phase 1 / Phase 2 | 450 | Genfleet Therapeutics (Shanghai) Inc.INDUSTRY | 1 | Sep 30, 2025 | clinicaltrials |
| NCT07196540 | IP rmhTNF-NC + Tislelizumab + Palliat RT for GIT Tumor Malignant Ascites After Failed Std Tx | not yet recruiting | Phase 2 | 78 | Sun Yat-sen UniversityOTHER | 0 | Sep 29, 2025 | clinicaltrials |
| NCT07104838 | Non-intubated Versus Intubated Anesthesia in Thoracoscopic Esophagectomy for Esophageal Cancer | not yet recruiting | N/A | 500 | The First Affiliated Hospital of Guangzhou Medical UniversityOTHER | 0 | Sep 25, 2025 | clinicaltrials |
| NCT07192627 | ESD in Locally Advanced Rectal Cancer Following CRT | not yet recruiting | — | 20 | Assiut UniversityOTHER | 1 | Sep 25, 2025 | clinicaltrials |
| NCT07192848 | Adebrelimab + Apatinib in Advanced HCC Post-Systemic Therapy | not yet recruiting | Phase 2 | 47 | Song PengOTHER | 1 | Sep 25, 2025 | clinicaltrials |
| NCT07141901 | Life Expectancy-informed Colorectal Cancer Screening(CRC) | not yet recruiting | N/A | 15,000 | Kathryn MartinezOTHER | 1 | Sep 24, 2025 | clinicaltrials |
| NCT07189520 | 1. SAFE-AI ONCO-TRACK: Multimodal GenAI for Early Detection of Minimal Residual Disease and Recurrence in Gastrointestinal Oncology(ONCO-TRACK) | not yet recruiting | — | 700 | Università Politecnica delle MarcheOTHER | 0 | Sep 24, 2025 | clinicaltrials |
| NCT07187284 | EDN Combined With TACE/HAIC and Second-Line Immune-Targeted Treatment Versus TACE/HAIC Alone in Locally Advanced HCC With Portal Vein Tumor Thrombosis After First-Line Therapy Failure: A Prospective, Multicenter, Randomized Controlled Trial | not yet recruiting | Phase 1 / Phase 2 | 62 | Zhongda HospitalOTHER | 1 | Sep 22, 2025 | clinicaltrials |
| NCT07183358 | Family-Supervised Prehabilitation to Reduce Postoperative Complications After Neoadjuvant Chemotherapy in Gastric Cancer | not yet recruiting | N/A | 90 | The Affiliated Hospital of Qingdao UniversityOTHER | 1 | Sep 19, 2025 | clinicaltrials |
| NCT07183566 | CT Volume Measurement of Hepatocellular Carcinoma | not yet recruiting | — | 66 | Assiut UniversityOTHER | 0 | Sep 19, 2025 | clinicaltrials |
| NCT07180134 | Health Informatics and Resistance Exercise for Symptom Management and Quality of Life in Post-Esophagectomy Patients | not yet recruiting | N/A | 90 | Chang Gung Memorial HospitalOTHER | 0 | Sep 18, 2025 | clinicaltrials |
| NCT07180459 | The Treatment of Unresectable Liver Cancer With E-TACE Combined With Donafenib：A Prospective, Single-arm, Multicenter, Observational Study | not yet recruiting | — | 118 | Xuhua DuanOTHER | 1 | Sep 18, 2025 | clinicaltrials |
| NCT07178613 | Assessment of the Dose Safety and Efficacy of Serine Combined With Fluorouracil Drugs | not yet recruiting | Phase 1 | 20 | The First Affiliated Hospital of Xinxiang Medical CollegeOTHER | 0 | Sep 17, 2025 | clinicaltrials |
| NCT07178717 | A Study to Characterize Encorafenib Plus Cetuximab as Rechallenge Treatment for BRAF V600E-mutant Metastatic Colorectal Cancer Patients After Previous Therapy With BRAF Inhibitors-based Combinations(REFISH) | not yet recruiting | Phase 2 | 25 | Vall d'Hebron Institute of OncologyOTHER | 1 | Sep 17, 2025 | clinicaltrials |
| NCT07160361 | Exploration of Postoperative Adjuvant Therapy for HCC Patients With Positive TB | not yet recruiting | Phase 4 | 56 | Second Affiliated Hospital of Xi'an Jiaotong UniversityOTHER | 0 | Sep 16, 2025 | clinicaltrials |
| NCT07175636 | QL1706 With Short-Course Radiotherapy and Chemotherapy for MSS Rectal Cancer | not yet recruiting | Phase 2 | 66 | Sun Yat-sen UniversityOTHER | 0 | Sep 16, 2025 | clinicaltrials |
| NCT07176052 | Expectation, Pain Outcomes, and Pain Medication Following Oncology Abdominal Surgery: A Cohort Study | not yet recruiting | — | 200 | Rigshospitalet, DenmarkOTHER | 0 | Sep 16, 2025 | clinicaltrials |
| NCT07161115 | Involve-site Radiotherapy Combined With Chemotherapy and Immunotherapy as Neoadjuvant Treatment for Locally Advanced Rectal Cancer(REFIRT) | not yet recruiting | Phase 2 | 60 | Longhao LiOTHER | 1 | Sep 15, 2025 | clinicaltrials |
| NCT07172087 | Construction and Empirical Research of the Applicable Baduanjin Protocol for Patients With Colorectal Cancer Enterostomy | not yet recruiting | N/A | 258 | Sichuan Cancer Hospital and Research InstituteOTHER | 1 | Sep 15, 2025 | clinicaltrials |
| NCT07172503 | Clinical Application of PET Imaging Targeting GPA33 in Malignant Tumors | not yet recruiting | N/A | 56 | Union Hospital, Tongji Medical College, Huazhong University of Science and TechnologyOTHER | 1 | Sep 15, 2025 | clinicaltrials |
| NCT07173244 | A Real-world Study of Adebrelimab-based Combination Regimens in the Treatment of Advanced Solid Tumors | not yet recruiting | — | 300 | Tianjin First Central HospitalOTHER | 0 | Sep 15, 2025 | clinicaltrials |
| NCT07169916 | Yueju Pill Combined With Standard Therapy In Advanced Biliary Tract Cancer(YJ-BTC) | not yet recruiting | N/A | 210 | Fudan UniversityOTHER | 1 | Sep 12, 2025 | clinicaltrials |
| NCT06664567 | Impact of a Proactive Strategy of General Practitioners on CRC Screening(DECORE) | not yet recruiting | — | 26,260 | University Hospital, BordeauxOTHER | 0 | Sep 11, 2025 | clinicaltrials |
| NCT07164690 | Low-Dose Radiotherapy in Patients With Advanced Esophageal Squamous Cell Carcinoma Resistant to First-Line Chemotherapy Combined With Immunotherapy | not yet recruiting | Phase 2 | 32 | Fudan UniversityOTHER | 0 | Sep 10, 2025 | clinicaltrials |
Data updated 24 days agoSource updated Nov 21, 2025source: clinicaltrials